BRAG2 Antibodies

Santa Cruz Biotechnology provides a broad selection of BRAG2 monoclonal antibodies for research applications. BRAG2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BRAG2, or BCR-ABL-regulated guanine nucleotide exchange factor 2, plays a critical role in cellular signaling pathways, particularly in the regulation of Rho GTPases. BRAG2 influences essential cellular processes such as cytoskeletal dynamics, cell migration, and proliferation. Understanding BRAG2 function is crucial for investigating cancer progression and other diseases. BRAG2 monoclonal antibodies enable precise detection and analysis of cellular mechanisms. Ongoing research with BRAG2 monoclonal antibodies continues to reveal new insights into cellular regulation and disease pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.